Very happy about this new ongoing collaboration with  CSL, a global biotechnology company with more than a century of experience in developing and delivering therapies and healthcare products. Through its businesses – CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor – CSL operates across plasma-derived therapies, plasma collection, vaccines and treatments related to iron deficiency and kidney disease.